BNB Surges to $796.29 on DEX Dominance and Institutional Adoption, Eyes ATH

Generated by AI AgentCoin World
Sunday, Jul 27, 2025 5:06 pm ET1min read
BNB
--
ETH
--
SOL
--
USDC
--
Aime RobotAime Summary

- BNB approaches $809 ATH at $796.29, driven by DEX dominance and institutional adoption.

- Daily DEX volume ($3.936B) surpasses Ethereum, with 180,000 new BNB addresses created in 24 hours.

- Whale activity and derivatives data show strong buy pressure, including a $10.2M 3x long position in BNB.

- Windtree Therapeutics allocates $520M BNB treasury, signaling institutional confidence in long-term value creation.

- Analysts highlight sustained DEX leadership and derivatives strength as key factors for potential further gains.

BNB, the native token of Binance Smart Chain, has surged to within $13 of its all-time high of $809.84, trading at $796.29 as of July 26, 2025, driven by a confluence of on-chain activity and institutional validation [1]. The token’s rally is underpinned by two key factors: dominance in decentralized exchange (DEX) volume and robust derivatives market support. DeFiLlama data shows BNB’s daily DEX volume hit $3.936 billion in the past 24 hours, surpassing

Ethereum
by $1.5 billion [2]. This surge is accompanied by a 62% spike in new
BNB
addresses, with 180,000 created in a single day, pushing the total to over 288,000 [3]. Over the past 30 days, cumulative DEX volume on the BNB Chain reached $189.2 billion, nearly double Solana’s $79 billion, signaling sustained adoption.

Derivatives data further reinforces bullish momentum. CoinGlass reports a Taker Buy/Sell Ratio of 1.1, indicating strong buy-side pressure, while Open Interest (OI) Weighted Funding Rates turned positive at 0.0141%, reflecting long-position holders paying premiums to maintain exposure [4]. Whale activity aligns with this trend: a $5.56 million

USDC
deposit into HyperLiquid was used to open a 3x long position in BNB worth $10.2 million, underscoring confidence from institutional actors [5].

A significant catalyst emerged as Windtree Therapeutics, a biotech firm, announced a $520 million BNB treasury fund, sourced via an Equity Line of Credit and Build and Build Corp. Patrick Horsman, CFA, at Horsman Holdings, described the move as a “forward-thinking approach to value creation,” emphasizing long-term institutional interest in digital assets [6]. This allocation amplifies BNB’s institutional profile, which analysts argue could accelerate its upward trajectory.

While the token hovers near its ATH, sustained momentum will be critical for a breakout. Maintaining current derivatives dynamics and DEX dominance is essential, though volatility and macroeconomic factors could influence short-term outcomes. The interplay of whale-driven liquidity, derivatives strength, and institutional capital suggests BNB’s next leg higher remains plausible—if not inevitable.

Source:

[1] [BNB Eyes $809 ATH: 2 Major Factors Fueling Its Next Leg](https://ambcrypto.com/bnb-eyes-809-ath-2-major-factors-fueling-its-next-leg/)

[2] DeFiLlama

[3] BSCscan

[4] CoinGlass

[5] Onchain Lens

[6] AMBCrypto